首页 › 弥漫性大B细胞淋巴瘤 › 威斯康星州 › Milwaukee
Milwaukee WI 弥漫性大B细胞淋巴瘤临床试验
16项针对 弥漫性大B细胞淋巴瘤的研究正在 Milwaukee及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
招募中观察性研究
- Children's Hospital of Wisconsin, Milwaukee
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
招募中2 期
- Medical College of Wisconsin, Milwaukee
- Drexel Town Square Health Center, Oak Creek · 距离 11 英里
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 距离 11 英里
- 以及另外 3 项
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
招募中2 期
- Medical College of Wisconsin ( Site 0103), Milwaukee
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
招募中1 期
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
招募中1 期
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of ARC-02 in B-cell NHL
招募中1 期
- Froedtert & Medical College of Wisconsin, Milwaukee
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
招募中1/2 期
- Medical College of Wisconsin, Milwaukee
Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma
招募中2 期
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
招募中1 期
- Froedtert & the Medical College of Wisconsin, Milwaukee
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
招募中观察性研究
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
DALY II USA/ MB-CART2019.1 for DLBCL
招募中2 期
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
招募中1 期
- Medical College of Wisconsin, Milwaukee
CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
招募中1/2 期
- Medical College of Wisconsin and Froedtert Hospital, Milwaukee
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
招募中2 期
- Medical College of Wisconsin, Milwaukee
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 距离 11 英里
Long-term Follow-up Study of Patients Receiving CAR-T Cells
招募中观察性研究
- Froedtert Hospital & Medical College of Wisconsin, Milwaukee
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
招募中2 期
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- 以及另外 4 项
其他城市的 弥漫性大B细胞淋巴瘤试验
- New York City, NY21 项研究
- Baldwin Park, CA19 项研究
- Chicago, IL18 项研究
- Houston, TX17 项研究
- Los Angeles, CA17 项研究
- Boston, MA16 项研究
- Nashville, TN15 项研究
- Portland, OR15 项研究
- Philadelphia, PA15 项研究
- Durham, NC14 项研究
- Dallas, TX13 项研究
- Seattle, WA12 项研究
Milwaukee的其他研究
- 乳腺癌23 项研究
- 非小细胞肺癌22 项研究
- 癌症（所有类型）22 项研究
- 肺癌21 项研究
- 多发性骨髓瘤21 项研究
- 前列腺癌20 项研究
- 滤泡性淋巴瘤19 项研究
- 胰腺癌18 项研究
- 非霍奇金淋巴瘤18 项研究
- 卵巢癌17 项研究
- 急性髓系白血病17 项研究
- 伯基特淋巴瘤16 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。